Lenalidomide is indicated for adult patients with multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lymphoma. The choice of strength and price is crucial for the patient's treatment plan. This article details the common strengths of lenalidomide, the market prices of different strengths, and the drug's safety profile, providing patients with comprehensive medication guidance.
What are the different strengths of lenalidomide?
Lenalidomide is available in various strengths on the global market. The main differences lie in the single-pill dose and the quantity per box, to meet the needs of different treatment stages.
Packaging Differences
The quantity per box varies between manufacturers.
Patients should choose the strength based on their doctor's prescription and their own treatment needs. If necessary, combining different strengths can achieve precise dosing.
How much does lenalidomide cost in different strengths?
The price of lenalidomide varies depending on the strength, manufacturer, and purchase channel. Below is a price reference for major manufacturers.
Actual purchase prices may fluctuate slightly due to exchange rates, shipping costs, etc. It is recommended to purchase through legitimate channels to ensure drug quality.
How safe is lenalidomide?
While lenalidomide is highly effective, its safety profile requires full understanding and attention from patients.
Common Adverse Reactions
These include hematologic toxicities such as neutropenia and thrombocytopenia, as well as systemic reactions such as fatigue and rash. These reactions can usually be controlled through dose adjustments.
Special Risk Warnings
This drug has definite embryo-fetal toxicity; patients of childbearing age must use reliable contraception. It may also increase the risk of thrombosis, especially when used in combination with other anticancer drugs.
Monitoring Requirements
Regular blood tests, liver and kidney function tests, etc., are required during treatment. For patients on long-term medication, the possibility of a second primary malignancy should also be monitored.
Patients should strictly follow their doctor's instructions and promptly report any discomfort. The doctor will adjust the treatment plan according to the specific situation, balancing efficacy and safety.
